BRCA2 and breast cancer: However, the risk of developing breast cancer by HRT may differ between BRCA1 and BRCA2 pathogenic variant carriers, and therefore we need to continue discussing carefully whether long-term estrogen treatment does not really increase the risk of breast cancer incidence.